logo
Firms reassess hiring in face of global headwinds

Firms reassess hiring in face of global headwinds

New Straits Times17 hours ago
PETALING JAYA: From global corporations to Malaysian businesses, companies across industries are reevaluating their business models to navigate a rapidly changing global economy.
Firms are restructuring operations to adapt to shifting geopolitical landscapes, technological advancements, and evolving climate targets, according to FMT.
Malaysia has not been spared, with Goodyear, one of the world's largest tyre companies, shuttering its Malaysian operations as part of a global cost-cutting strategy.
Meanwhile, Astro Malaysia, the country's leading content and entertainment company, has introduced company-wide measures to streamline its operations in line with broader shifts seen globally across the media and technology sectors.
Why now? Three major trends are driving this wave of transformation.
Geopolitics, trade tensions force rethink
FMT said after years of globalisation, the pendulum is swinging back. Trade is being reshaped by geopolitics, with countries pushing to safeguard supply chains, even if it drives up costs.
The US has hiked tariffs on China and hinted at more restrictions affecting Southeast Asia. Despite holding steady thus far, Malaysia's electrical and electronics exports remain vulnerable to mounting geopolitical headwinds.
Meanwhile, businesses are streamlining supply chains to mitigate geopolitical risks. Friendshoring, or locating production in "friendly" countries, is on the rise, and Malaysia is benefiting.
"Intel, Infineon and Micron have all invested heavily in new chip facilities here. Even Chinese firms are shifting production to Malaysia to navigate US trade restrictions.
"But not all sectors are thriving. Semiconductor demand cooled last year after a pandemic-driven surge, prompting layoffs and hiring freezes in Penang's manufacturing corridors," the portal said.
The glove industry, a sector that boomed during the Covid-19 pandemic, also saw a downturn in 2023, leading Top Glove to shut down factories in China and Vietnam.
The tech industry has also seen significant workforce reductions. For instance, major Silicon Valley firms like Meta and Microsoft collectively laid off over 30,000 employees globally earlier this year - nearly 20,000 in the San Francisco Bay Area alone- as companies recalibrated after pandemic-era overhiring and shifted focus towards AI and automation. Similar cuts have also been felt closer to home, with layoffs impacting tech hubs in Singapore.
The portal said the retail sector is facing its own challenges, with projections indicating over 15,000 store closures in the US this year, potentially leading to more than 200,000 job losses, as consumer habits shift and economic pressures mount.
"Meanwhile, the automotive industry is undergoing significant restructuring. For example, Thyssenkrupp announced plans to cut around 1,800 jobs due to ongoing weakness in the automotive sector it supplies, citing declining production volumes and uncertainty due to potential new tariffs," it added.
For many businesses, this is what downsizing looks like: scaling back in markets promising lower returns and doubling down in areas with longer-term potential.
The energy transition
The shift toward cleaner energy is another major factor. As climate goals tighten, energy producers and heavy industries are changing how they operate, and who they hire, the portal said.
In Malaysia, government-linked companies Petronas and Tenaga Nasional are increasingly moving into renewables, areas that require different expertise and hence evolving headcount.
"The same story is playing out globally. Car makers are investing in electric vehicles and trimming roles tied to combustion engines. Power companies are moving from coal to solar and wind, prompting retraining and reorganisation.
"Malaysia's own energy roadmap calls for a pivot to low-carbon sources, bringing new jobs in solar, hydrogen and EV charging, while phasing out others."
To support this transition, the government and industry are investing in retraining programmes, helping oil and gas workers move into green tech.
But the clock is ticking. The companies acting now are those hoping to stay ahead of the curve, not get left behind.
Doing more with less: AI, digital transformation
In addition to responding to external shocks, companies are also pursuing greater productivity. Thanks to artificial intelligence (AI) and automation, many tasks, once performed by humans, are now handled by algorithms.
Meanwhile, local banks are grappling with tightening regulations and rising non-performing loans, forcing them to streamline branches and retrain staff for digital banking operations.
They are also increasingly using AI for customer service, reducing the need for large call centre teams, the portal said.
In retail, brick-and-mortar chains are closing storefronts amid fluctuations in consumer spending and the rise of e-commerce platforms like Amazon and Shopee, sparking realignments into logistics and digital marketing over in-person sales.
"The trend is global. A Bloomberg Intelligence report suggests up to 200,000 banking jobs worldwide could be lost to AI in the next five years.
In Malaysia, ByteDance, TikTok's parent company, cut hundreds of jobs last year from its KL moderation team, as AI tools replaced many human screeners."
Even startups are feeling the shift, the portal said. With investor money harder to come by, firms are prioritising lean teams supported by software tools.
Hiring has slowed, and many companies are discovering they can maintain output with fewer people, provided they're using the right tech.
For workers, this means reskilling is no longer optional. The most vulnerable roles are those that are easily automated. Developing tech fluency and adaptability is now the safest bet.
A new business mindset
All these moves, whether in response to geopolitics, AI or climate goals, reflect a broader shift in corporate thinking, the portal said. Companies are restructuring not because they're failing, but because they're evolving.
Global firms are recalibrating their operations, and Malaysian workers and businesses are part of that equation.
Some jobs will disappear while others will be transformed. But new roles will also be created, especially in sectors like advanced manufacturing, AI, and clean energy. The key is readiness. Those who anticipate change and adapt early will have the edge.
In a volatile global economy, staying competitive means knowing when to pivot. The companies doing that now are likely to be the ones still standing a decade from now.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Brii Biosciences Announces Licensing Agreement with Joincare Group for Rights to BRII-693 in Greater China
Brii Biosciences Announces Licensing Agreement with Joincare Group for Rights to BRII-693 in Greater China

Malaysian Reserve

timean hour ago

  • Malaysian Reserve

Brii Biosciences Announces Licensing Agreement with Joincare Group for Rights to BRII-693 in Greater China

Joincare Group to lead the clinical development and commercialization of BRII-693 in Greater China Brii Biosciences retains ex-Greater China rights to address the global antimicrobial resistance threats and continues investment in other priority pipeline assets DURHAM, N.C. and BEIJING, July 3, 2025 /PRNewswire/ — Brii Biosciences Limited ('Brii Bio,' stock code: a biotechnology company developing therapies to improve patient health and choice across diseases with high unmet medical needs, today announced that it has entered into a license and technology transfer agreement with Joincare Pharmaceutical Group Industry Co., Ltd ('Joincare Group'). Joincare Group will obtain an exclusive license from Brii Bio for the research, development, and commercialization of BRII-693 in the Greater China region. Under the terms of the agreement, Joincare Group will assume full responsibility for the development, regulatory approval and commercialization of BRII-693 in Greater China. In return, Brii Bio has received an upfront payment and will receive additional development and commercial milestone payments upon certain future milestone events plus tiered royalties on net product sales. BRII-693 is a novel synthetic lipopeptide in development for the treatment of critically ill patients with multidrug- and extensively drug-resistant (MDR/XDR) gram-negative bacterial infections, particularly those caused by carbapenem-resistant Acinetobacter baumannii (CRAB), Pseudomonas aeruginosa (CRPA) and Enterobacterales (CRE). Discovered through iterative structural modifications of the polymyxin scaffold, BRII-693 was designed to enhance antibacterial potency while reducing the toxicity commonly associated with older polymyxin agents such as renal and neuro-toxicities. In phase 1 studies, BRII-693 demonstrated a favorable safety, tolerability, and PK profile in healthy non-Chinese and Chinese participants. Brii Bio received IND approval from CDE of NMPA for a Phase 1 PK bridging study in China supporting a future Phase 3 registrational trial in patients with hospital-acquired bacterial pneumonia/ventilator-associated bacterial pneumonia. Dr. Zhi Hong, Chairman and Chief Executive Officer of Brii Bio, commented: 'The growing threat of antimicrobial resistance in Greater China underscores the urgency for novel hospital antibiotics. With Joincare Group's proven capabilities in manufacturing and commercializing hospital antibiotics, we found the ideal partner to accelerate the development and commercialization of BRII-693. This partnership enables us to deliver a critical care medicine to Chinese patients facing life threatening infections.' Mr. Nanqi Lin, Chief Executive Officer of Joincare Group, stated, 'The Company has a long-standing track record of excellence in innovative drug research and development, underpinned by deep scientific expertise and a robust R&D platform. Driven by Brii Bio's well-established R&D system, the BRII-693 project demonstrated strong innovation and scientific rigor. Early data showing encouraging results in terms of therapeutic potential, pharmacodynamics, and pharmacokinetics, suggesting BRII-693's high potential to become a best-in-class therapy to address the critical unmet clinical needs. We are confident in the clinical prospects of BRII-693. This collaboration further strengthened Joincare Group's strategic positioning in the anti-infection disease area. We look forward to launching this asset soon, providing patients with more high-quality treatment options.' About BRII-693 BRII-693 is a novel synthetic lipopeptide in development for the treatment of critically ill patients with MDR/XDR gram-negative bacterial infections, especially carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa. Brii Bio holds exclusive global rights to develop and commercialize BRII-693. About Brii Bio Brii Biosciences Limited ('Brii Bio', stock code: is a biotechnology company developing therapies to address major public health challenges where patients experience high unmet medical needs, limited choice and significant social stigmas. With a focus on infectious diseases, the Company is advancing a broad pipeline of unique therapeutic candidates with lead programs against hepatitis B virus (HBV) infection. The Company is led by a visionary and experienced leadership team and has operations in key biotech hubs, including Raleigh-Durham, the San Francisco Bay Area, Beijing and Shanghai. For more information, visit About Joincare Group Established in 1992, Joincare Group (Joincare Pharmaceutical Group Industry Co., Ltd) is an innovative scientific research-based integrated pharmaceutical group after many years of steady operation and rapid development. The group owns two major listed companies, Joincare and Livzon Pharmaceutical, as well as more than 20 major holding subsidiaries. The company has always adhered to the concept of scientific and technological innovation as the cornerstone, implementing a dual-driver strategy focused on innovative drugs and high-barrier complex formulation technology platforms, and has carried out rich pipeline layouts around respiratory, anti-infective, gastrointestinal, assisted reproduction, psychiatric, oncology and other areas of significant clinical needs, forming a rich and diversified product matrix and pipeline of drugs under development. Forward-looking Statements This contains the disclosure of some forward-looking statements. Except for statements of facts, all other statements can be regarded as forward-looking statements, that is, about our or our management's intentions, plans, beliefs, or expectations that will or may occur in the future. Such statements are assumptions and estimates made by our management based on its experience and knowledge of historical trends, current conditions, expected future development and other related factors. This forward-looking statement does not guarantee future performance, and actual results, development and business decisions may not match the expectations of the forward-looking statement. Our forward-looking statements are also subject to a large number of risks and uncertainties, which may affect our short-term and long-term performance.

Li Li of Next Capital Named in Caijing Magazine's 'Top 50 Global Chinese Venture Capitalists'
Li Li of Next Capital Named in Caijing Magazine's 'Top 50 Global Chinese Venture Capitalists'

The Sun

timean hour ago

  • The Sun

Li Li of Next Capital Named in Caijing Magazine's 'Top 50 Global Chinese Venture Capitalists'

NEW YORK, USA - Media OutReach Newswire - 3 July 2025 - Recently, Li Li, Founding Partner of Next Capital, was honored as one of Caijing Magazine's 'Top 50 Global Chinese Venture Capitalists'. Awarded by Caijing, an authoritative media platform focusing on global industry-finance integration, this accolade highlights Chinese investment leaders who have consistently generated excess returns in major global VC markets and driven technological transformation and industrial innovation through forward-looking strategic deployments. Since entering the technology investment field in 2011, Li Li has led angel or early-stage investments in companies such as LexinFintech (NASDAQ: LX), TuanChe Limited (NASDAQ: TC), Tiger Brokers (NASDAQ: TIGR), Niuguwang, PingCAP, HOSE, 77irCloud, Caibeike, Lockin, Krazybee (India), Chi Forest, Walnut Coding, PandaRemit, ShopLazza, XellSmart, Weiming Shiguang, and others. She is also the founder of Xiaofanzhuo, a leading Chinese venture capital service platform. Before transitioning to early-stage tech investment, Li Li had a decade of experience in tech financial media, serving as Editorial Board Member and Chief Reporter for the Chinese edition of Information Week, and Deputy Editor-in-Chief of Ceocio China. Notably, she is the only Chinese journalist to have conducted an exclusive interview with Amazon founder Jeff Bezos. This background has endowed Li Li with profound insights into technology-driven business innovation. Her belief in technological advancement has shaped her early-stage investment style over the past 15 years. 'We seek out each generation of young people who use tech innovation to change the world. Every era produces its own heroes' Li Li said. The global emergence of Chinese venture capitalists reflects not only China's economic ascent and increasing international presence, but also the sharp instinct and execution of Chinese entrepreneurs and investors in the global innovation ecosystem. Next Capital looks forward to partnering with more innovators to 'Discover the Next Big Thing.' Founded in 2017, Next Capital is an early-stage investment fund focused on the technology sector. As 'the first money for innovators,' the firm is committed to backing technology-driven business innovation and partnering with visionary founders to shape the future. Its investment portfolio spans artificial intelligence, hard technology, digital healthcare, global tech expansion, biotech & life sciences, enterprise services, cloud-native technologies, specialized & innovative sectors, robotics, etc. Its portfolio features a number of standout companies such as Chi Forest, PandaRemit, FINDING UNICORN, ShopLazza, XellSmart, Atantares, Weiming Shiguang, GLZHealth, SIBIONICS, among other forward-thinking enterprises. Next Capital's venture support initiatives—including 'NEXT Entrepreneurship Banquet,' 'NEXT Innovation Camp,' and 'NEXT LEAGUE'—are designed to provide systematic, end-to-end support for entrepreneurs from startup to IPO. These programs have fostered a dynamic ecosystem of new-economy Chinese entrepreneurs, reaching and influencing over 80,000 individuals across Greater China, North America, Europe, Singapore, and beyond.

Gold heads for weekly gain on US fiscal concerns after tax-cut bill
Gold heads for weekly gain on US fiscal concerns after tax-cut bill

New Straits Times

timean hour ago

  • New Straits Times

Gold heads for weekly gain on US fiscal concerns after tax-cut bill

NEW YORK: Gold held steady on Friday, poised for a weekly gain as US President Donald Trump's tax-cut and spending bill passed in Congress, raising fiscal concerns, though stronger-than-expected US jobs data capped bullion's gains. FUNDAMENTALS Spot gold was flat at US$3,328.36 per ounce, as of 0029 GMT. Bullion is up 1.7 per cent this week. US gold futures edged down 0.1 per cent to US$3,337.90. Trump's tax-cut legislation cleared its final hurdle in the US Congress on Thursday, as the Republican-controlled House of Representatives narrowly approved a massive package that would fund his domestic agenda and push millions of Americans off health insurance. The labor market data on Thursday showed US firms added a more-than-expected 147,000 jobs in June and the unemployment rate unexpectedly fell to 4.1 per cent. Solid job gains bolstered the case for the Federal Reserve to hold interest rates steady. Fed funds futures traders are now pricing in a 50-basis-point rate cut this year, starting October. Meanwhile, Trump announced that letters specifying tariff rates on imports would begin being sent out Friday, signaling a shift from earlier pledges to negotiate individual trade deals. Non-yielding bullion, considered a safe-haven asset during geopolitical and economic uncertainties, tends to perform well in a low-interest-rate environment. On Ukraine, Trump said a phone call with Russian President Vladimir Putin yielded no progress in resolving the conflict, while the Kremlin stated that Moscow would continue addressing the "root causes" of the crisis. Platinum prices have limited room to rise further after a record quarterly rally, analysts and traders said, with Chinese imports expected to soften and South African output likely to recover against a backdrop of still-muted auto sector demand. Spot silver fell 0.3 per cent to US$36.73 per ounce, platinum rose 0.8 per cent to US$1,378.30 and palladium was up 0.1 per cent at US$1,137.94. All three metals were headed for weekly gains.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store